First Trust Advisors LP Ardelyx, Inc. Transaction History
First Trust Advisors LP
- $127 Billion
- Q3 2025
A detailed history of First Trust Advisors LP transactions in Ardelyx, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 182,600 shares of ARDX stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
182,600
Previous 335,597
45.59%
Holding current value
$1.07 Million
Previous $1.32 Million
23.42%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARDX
# of Institutions
244Shares Held
161MCall Options Held
697KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA18.4MShares$108 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$103 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X013.8MShares$81.1 Million0.04% of portfolio
-
Macquarie Group LTD Australia, C310.5MShares$61.4 Million0.07% of portfolio
-
State Street Corp Boston, MA9.72MShares$57 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $908M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...